Ameritas Investment Partners Inc. lifted its stake in shares of Medidata Solutions, Inc. (NASDAQ:MDSO) by 350.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,400 shares of the company’s stock after acquiring an additional 16,651 shares during the quarter. Ameritas Investment Partners Inc.’s holdings in Medidata Solutions were worth $1,673,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of MDSO. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Medidata Solutions by 10.5% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,186 shares of the company’s stock valued at $171,000 after acquiring an additional 208 shares during the period. Parametrica Management Ltd acquired a new position in shares of Medidata Solutions during the second quarter valued at approximately $216,000. Cubist Systematic Strategies LLC acquired a new position in shares of Medidata Solutions during the second quarter valued at approximately $227,000. Invictus RG acquired a new position in shares of Medidata Solutions during the first quarter valued at approximately $233,000. Finally, ETF Managers Group LLC acquired a new position in shares of Medidata Solutions during the second quarter valued at approximately $233,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

A number of research firms recently commented on MDSO. Jefferies Group LLC reiterated a “hold” rating and set a $78.00 price objective on shares of Medidata Solutions in a research note on Tuesday, August 22nd. Royal Bank Of Canada began coverage on shares of Medidata Solutions in a research note on Tuesday, September 19th. They set a “sector perform” rating and a $82.00 price objective on the stock. Needham & Company LLC reiterated a “buy” rating and set a $90.00 price objective (up previously from $75.00) on shares of Medidata Solutions in a research note on Friday, July 21st. Zacks Investment Research upgraded shares of Medidata Solutions from a “sell” rating to a “hold” rating in a research note on Wednesday, September 20th. Finally, Citigroup Inc. reiterated a “buy” rating and set a $94.00 price objective (up previously from $77.00) on shares of Medidata Solutions in a research note on Monday, July 10th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $84.64.

In related news, COO Michael L. Capone sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total transaction of $372,650.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 5.80% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was posted by Daily Political and is the property of of Daily Political. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.dailypolitical.com/2017/10/15/medidata-solutions-inc-mdso-shares-bought-by-ameritas-investment-partners-inc.html.

Shares of Medidata Solutions, Inc. (NASDAQ:MDSO) traded up 0.70% during mid-day trading on Friday, reaching $80.01. 240,824 shares of the company were exchanged. Medidata Solutions, Inc. has a 12 month low of $46.10 and a 12 month high of $85.92. The stock has a market capitalization of $4.53 billion, a P/E ratio of 129.26 and a beta of 1.77. The firm has a 50-day moving average price of $76.67 and a 200 day moving average price of $73.08.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings results on Tuesday, July 18th. The company reported $0.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.28 by $0.03. The business had revenue of $137.41 million during the quarter, compared to the consensus estimate of $134.28 million. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. Medidata Solutions’s revenue for the quarter was up 19.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.24 earnings per share. Equities research analysts anticipate that Medidata Solutions, Inc. will post $1.29 EPS for the current fiscal year.

Medidata Solutions Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions, Inc. (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.